{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:46:14Z","timestamp":1791582374637,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tehran University of Medical Sciences","award":["91.1.30 17019"],"award-info":[{"award-number":["91.1.30 17019"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.lfs.2015.12.014","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T18:07:40Z","timestamp":1449943660000},"page":"34-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes"],"prefix":"10.1016","volume":"145","author":[{"given":"Solaleh","family":"Emamgholipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Hossein-nezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Askarisadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lfs.2015.12.014_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(04)00933-0","article-title":"Environmental risk factors in multiple sclerosis aetiology","volume":"3","author":"Marrie","year":"2004","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.lfs.2015.12.014_bb0010","doi-asserted-by":"crossref","first-page":"e76555","DOI":"10.1371\/journal.pone.0076555","article-title":"Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease","volume":"8","author":"Emamgholipour","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.lfs.2015.12.014_bb0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.lfs.2015.12.014_bb0020","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.brainresrev.2007.07.005","article-title":"Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology","volume":"56","author":"Schreibelt","year":"2007","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2015.12.014_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbadis.2010.06.011","article-title":"Radical changes in multiple sclerosis pathogenesis","volume":"1812","author":"van Horssen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.12.014_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.05.010","article-title":"Pathology and disease mechanisms in different stages of multiple sclerosis","volume":"333","author":"Lassmann","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.lfs.2015.12.014_bb0035","doi-asserted-by":"crossref","first-page":"961863","DOI":"10.1155\/2014\/961863","article-title":"Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment","volume":"2014","author":"Gironi","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.12.014_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2012.07.045","article-title":"Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale","volume":"321","author":"Oliveira","year":"2012","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.lfs.2015.12.014_bb0045","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.freeradbiomed.2008.09.023","article-title":"Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression","volume":"45","author":"van Horssen","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.lfs.2015.12.014_bb0050","doi-asserted-by":"crossref","first-page":"e65184","DOI":"10.1371\/journal.pone.0065184","article-title":"Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis","volume":"8","author":"Fiorini","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.lfs.2015.12.014_bb0055","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clinbiochem.2012.01.023","article-title":"Peripheral oxidative stress in relapsing\u2013remitting multiple sclerosis","volume":"45","author":"Tasset","year":"2012","journal-title":"Clin. Biochem."},{"issue":"10","key":"10.1016\/j.lfs.2015.12.014_bb0060","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1172\/JCI38902","article-title":"The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice","volume":"119","author":"Zhang","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.lfs.2015.12.014_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.yexmp.2013.12.010","article-title":"SIRT1 is decreased during relapses in patients with multiple sclerosis","volume":"96","author":"Tegla","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"7","key":"10.1016\/j.lfs.2015.12.014_bb0070","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1134\/S0006297909070013","article-title":"Function of SIRT1 in physiology","volume":"74","author":"Kong","year":"2009","journal-title":"Biochemistry (Mosc)"},{"issue":"2","key":"10.1016\/j.lfs.2015.12.014_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1517\/14728222.2012.648926","article-title":"SIRT1: new avenues of discovery for disorders of oxidative stress","volume":"16","author":"Chong","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.03.015","article-title":"SIRT1 and NAD as regulators of ageing","volume":"105","author":"Rehan","year":"2014","journal-title":"Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.12.014_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2014.02.001","article-title":"Sirtuin 1 attenuates oxidative stress via upregulation of superoxide dismutase 2 and catalase in astrocytes","volume":"269","author":"Cheng","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.lfs.2015.12.014_bb0090","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jnutbio.2011.03.012","article-title":"Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights","volume":"23","author":"Yun","year":"2012","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.lfs.2015.12.014_bb0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/emmm.201302451","article-title":"SIRT1 and SIRT2: emerging targets in neurodegeneration","volume":"5","author":"Donmez","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/156720209787466019","article-title":"Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection","volume":"6","author":"Pall\u00e0s","year":"2009","journal-title":"Curr. Neurovasc. Res."},{"issue":"3","key":"10.1016\/j.lfs.2015.12.014_bb0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","article-title":"The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy","volume":"251","author":"Gilgun-Sherki","year":"2004","journal-title":"J. Neurol."},{"issue":"37","key":"10.1016\/j.lfs.2015.12.014_bb0110","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.2174\/09298673113209990156","article-title":"Advances in antioxidative therapy of multiple sclerosis","volume":"20","author":"Miller","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.2011.00916.x","article-title":"Melatonin as a natural ally against oxidative stress: a physicochemical examination","volume":"51","author":"Galano","year":"2011","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.1995.tb00133.x","article-title":"A review of the evidence supporting melatonin's role as an antioxidant","volume":"18","author":"Reiter","year":"1995","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1600-079X.2003.00092.x","article-title":"Regulation of antioxidant enzymes: a significant role for melatonin","volume":"36","author":"Rodriguez","year":"2004","journal-title":"J. Pineal Res."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.12.014_bb0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2011.11.003","article-title":"Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis","volume":"314","author":"Melamud","year":"2012","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2015.12.014_bb0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/2319-4170.125885","article-title":"Serum levels of melatonin and cytokines in multiple sclerosis","volume":"37","author":"Farhadi","year":"2014","journal-title":"Biomed J."},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0140","first-page":"91","article-title":"Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis","volume":"14","author":"Gholipour","year":"2015","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.12.014_bb0145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jns.2015.03.040","article-title":"Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: a preliminary study","volume":"353","author":"Damasceno","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2015.12.014_bb0150","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s11064-014-1347-6","article-title":"Melatonin acts as antioxidant and improves sleep in MS patients","volume":"39","author":"Adamczyk-Sowa","year":"2014","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.lfs.2015.12.014_bb0155","first-page":"543","article-title":"Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients","volume":"65","author":"Adamczyk-Sowa","year":"2014","journal-title":"J. Physiol. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.12.014_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2013.02.012","article-title":"Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course","volume":"257","author":"Miller","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.12.014_bb0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2004.03.004","article-title":"Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis","volume":"152","author":"Hong","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.lfs.2015.12.014_bb0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12192-008-0075-8","article-title":"Heat-shock response protects peripheral blood mononuclear cells (PBMCs) from hydrogen peroxide-induced mitochondrial disturbance","volume":"14","author":"Chiu","year":"2009","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2015.12.014_bb0180","series-title":"The Protein Protocols Handbook","first-page":"17","article-title":"The Bradford method for protein quantitation","author":"Kruger","year":"2009"},{"issue":"6","key":"10.1016\/j.lfs.2015.12.014_bb0185","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.12.014_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2008.06.029","article-title":"Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity","volume":"274","author":"Gonsette","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2015.12.014_bb0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jpi.12203","article-title":"Melatonin treatment improves primary progressive multiple sclerosis: a case report","volume":"58","author":"Lopez-Gonzalez","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2015.12.014_bb0200","article-title":"Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis","author":"Karlik","year":"2014","journal-title":"Clin Biochem."},{"issue":"6","key":"10.1016\/j.lfs.2015.12.014_bb0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10571-013-9944-5","article-title":"Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic","volume":"33","author":"Ljubisavljevic","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2015.12.014_bb0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1475-2891-13-62","article-title":"Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing\u2013remitting multiple sclerosis","volume":"13","author":"Socha","year":"2014","journal-title":"Nutr. J."},{"issue":"10","key":"10.1016\/j.lfs.2015.12.014_bb0215","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bcp.2011.07.092","article-title":"Redox regulation of cellular stress response in multiple sclerosis","volume":"82","author":"Pennisi","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.18388\/abp.1993_4877","article-title":"Red cell superoxide dismutase and catalase activity in multiple sclerosis","volume":"40","author":"Kopff","year":"1993","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.lfs.2015.12.014_bb0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2014.02.042","article-title":"Increased microglial catalase activity in multiple sclerosis grey matter","volume":"1559","author":"Gray","year":"2014","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/187221407779814561","article-title":"Melatonin as antioxidant under pathological processes","volume":"1","author":"Tom\u00e1s-Zapico","year":"2007","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discovery"},{"issue":"4\u20136","key":"10.1016\/j.lfs.2015.12.014_bb0235","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mam.2011.10.006","article-title":"Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation","volume":"32","author":"Hybertson","year":"2011","journal-title":"Mol. Asp. Med."},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20110663","article-title":"Cardioprotection against ischaemia\/reperfusion by vitamins C and E plus n\u22123 fatty acids: molecular mechanisms and potential clinical applications","volume":"124","author":"Rodrigo","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.lfs.2015.12.014_bb0245","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1172\/JCI41563","article-title":"Sirt1 activation protects the mouse renal medulla from oxidative injury","volume":"120","author":"He","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.lfs.2015.12.014_bb0250","doi-asserted-by":"crossref","first-page":"L816","DOI":"10.1152\/ajplung.00323.2013","article-title":"SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism","volume":"306","author":"Yao","year":"2014","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.lfs.2015.12.014_bb0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2051-5960-2-3","article-title":"SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease","volume":"2","author":"Khan","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.lfs.2015.12.014_bb0260","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.4049\/jimmunol.1202584","article-title":"Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets","volume":"190","author":"Nimmagadda","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2015.12.014_bb0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/08923970802331943","article-title":"Antioxidant therapy in multiple sclerosis","volume":"31","author":"Mirshafiey","year":"2009","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"8","key":"10.1016\/j.lfs.2015.12.014_bb0270","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.freeradbiomed.2010.07.013","article-title":"Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions","volume":"49","author":"van Horssen","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.lfs.2015.12.014_bb0275","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1007\/s00221-014-3946-5","article-title":"Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis","volume":"232","author":"Kashani","year":"2014","journal-title":"Exp. Brain Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515301090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515301090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T15:21:12Z","timestamp":1599924072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320515301090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":55,"alternative-id":["S0024320515301090"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2015.12.014","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2015.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}